Skip to content

Treatment outcome of Co-enzyme Q10 on infertility

Treatment outcome of Co-enzyme Q10 (CoQ10) following varicocelectomy

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201110034181N7
Enrollment
50
Registered
2011-10-26
Start date
2010-03-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male infertility. male infertility

Interventions

Intervention 1: Oral Co-enzyme Q10 100mg/OD, for 6 months. Intervention 2: Oral placebo/OD for 6 months.
Treatment - Drugs
Placebo
Oral Co-enzyme Q10 100mg/OD, for 6 months
Oral placebo/OD for 6 months

Sponsors

Tabriz university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Inclusion criteria: candidacy for varicocelectomy. Exclusion criteria: positive history for varicocelectomy or other gentourinary surgery of any kind; positive history for genitourinary infection; azoospermia; appearance of varicocelectomy complications; use of drugs in the last 3 months; smoking in the last 6 months; alchohol consumption in the last 6 months.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sperm count. Timepoint: 6 months. Method of measurement: microscope.;Sperm motility. Timepoint: 6 months. Method of measurement: microscope.;Semen volume. Timepoint: 6 months. Method of measurement: volumeter.;Sperm morphology. Timepoint: 6 months. Method of measurement: microscope.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Hemmati

Tabriz university of medical sciences

hemmati.mehdi@gmail.com+98 41 1658 4305

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026